About the journal
Clinical Immunology Communications is an open-access journal published by Elsevier in United States, publishing in english. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 8 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier
- ISSN
- 2772-6134
- Country
- United States
- Languages
- english
- Access
- Open access
- Articles in DOAJ
- 116
- Declared review time
- 8 weeks
- Declared peer-review model
- peer_review
Index listings
- DOAJ · 2022-02-28
- Indexing
- DOAJ
- APC
- —
- Declared review time (DOAJ)
- 8 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
116
Most recent article
5 months ago
Average review time (journal-declared via DOAJ)
8weeks
Works in OpenAlex
140
Last recorded publication year
2026
h-index
10
i10-index
10
From OpenAlex open data (CC0).
Editorial & policy10
- Last DOAJ review date
- 2026-04-27
- Added to DOAJ
- 2022-02-28
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 96%
- ORCID iDs in current deposits
- 91%
- Deposits licence metadata at Crossref
- ✓
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 9918697481206676
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 and COVID-19 Research
- Immunodeficiency and Autoimmune Disorders
- Immunodeficiency and Autoimmune Disorders
- COVID-19 Clinical Research Studies
- COVID-19 Clinical Research Studies
- Immune Cell Function and Interaction
- Immune Cell Function and Interaction
Show all subjects (50)
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Long-Term Effects of COVID-19
- Long-Term Effects of COVID-19
- Blood disorders and treatments
- Blood disorders and treatments
- Educational Robotics and Engineering
- Human auditory perception and evaluation
- Diverse Scientific and Economic Studies
- Peripheral Neuropathies and Disorders
- Diverse Scientific and Economic Studies
- Human auditory perception and evaluation
- Systemic Lupus Erythematosus Research
- Platelet Disorders and Treatments
- Autoimmune and Inflammatory Disorders Research
- Inflammasome and immune disorders
- Educational Robotics and Engineering
- Systemic Lupus Erythematosus Research
- Platelet Disorders and Treatments
- Respiratory viral infections research
- Inflammasome and immune disorders
- Autoimmune and Inflammatory Disorders Research
- Dermatology and Skin Diseases
- Immune responses and vaccinations
- Respiratory viral infections research
- Peripheral Neuropathies and Disorders
- Immune responses and vaccinations
- Dermatology and Skin Diseases
- Vaccine Coverage and Hesitancy
- T-cell and B-cell Immunology
- Gut microbiota and health
- Vaccine Coverage and Hesitancy
- Rheumatoid Arthritis Research and Therapies
- COVID-19 and Mental Health
- Asthma and respiratory diseases
- Asthma and respiratory diseases
- Rheumatoid Arthritis Research and Therapies
- Immune Response and Inflammation
- T-cell and B-cell Immunology
- Gut microbiota and health
- COVID-19 and Mental Health
- Immune Response and Inflammation
Keywords (DOAJ)
- autoimmunity
- hypersensitivity
- allergy
- tumor immunology
- immunodeficiencies
- vaccine
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ